Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16352931rdf:typepubmed:Citationlld:pubmed
pubmed-article:16352931lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0120107lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0279752lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C0677850lld:lifeskim
pubmed-article:16352931lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:16352931pubmed:issue13lld:pubmed
pubmed-article:16352931pubmed:dateCreated2005-12-14lld:pubmed
pubmed-article:16352931pubmed:abstractTextGoserelin (GOS) therapy in an adjuvant setting for estrogen receptor(ER)-positive premenopausal patients with breast cancer was assessed in a randomised comparative study.lld:pubmed
pubmed-article:16352931pubmed:languagejpnlld:pubmed
pubmed-article:16352931pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:citationSubsetIMlld:pubmed
pubmed-article:16352931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16352931pubmed:statusMEDLINElld:pubmed
pubmed-article:16352931pubmed:monthDeclld:pubmed
pubmed-article:16352931pubmed:issn0385-0684lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:OhashiYasuoYlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:YamamotoNaoto...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:TsujinakaTosh...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:OhnoShinjiSlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:SakuMotonoriMlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:AbeOsahikoOlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:NomuraYasuoYlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:MiuraShigetoSlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:IshidaTsunehi...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:KimuraTsunehi...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:KohJunichiJlld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:MiyauchiMitsu...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:MitsuyamaShos...lld:pubmed
pubmed-article:16352931pubmed:authorpubmed-author:YoshikawaNobu...lld:pubmed
pubmed-article:16352931pubmed:issnTypePrintlld:pubmed
pubmed-article:16352931pubmed:volume32lld:pubmed
pubmed-article:16352931pubmed:ownerNLMlld:pubmed
pubmed-article:16352931pubmed:authorsCompleteYlld:pubmed
pubmed-article:16352931pubmed:pagination2071-7lld:pubmed
pubmed-article:16352931pubmed:dateRevised2009-11-3lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:meshHeadingpubmed-meshheading:16352931...lld:pubmed
pubmed-article:16352931pubmed:year2005lld:pubmed
pubmed-article:16352931pubmed:articleTitle[Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].lld:pubmed
pubmed-article:16352931pubmed:affiliationDept. of Surgery, Kitakyushu Municipal Medical Center.lld:pubmed
pubmed-article:16352931pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16352931pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:16352931pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16352931pubmed:publicationTypeMulticenter Studylld:pubmed